Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023

Stock Price vs Company Growth
1d
1.0%
1w
2.6%
1m
2.5%
3m
19.8%
6m
16.1%
1y
23.9%
all
27.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 741 1.0%
673
946
Company Overview

Sales
1,906 Cr
Growth: -4.3%
Profit after Tax
240 Cr
Growth: -10.0%
Small Cap
6,716 Cr
P/E: 28.0x
Industry P/E: 33.1x
Fundamentals

Sales (Cr) ₹ 1,906
Growth -4.3%
EBITDA 23.3%
P/S 3.5x
Dividend 0.5%
P/E 28.0x
Book Value ₹ 228
PEG Ratio -6.5x
ROE 11.9%
P/B 3.2x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Investors (13)
Followers (1)